Inogen Inc (INGN) — 8-K Filings

8-K Filings (22)

• 8-K Filing — Apr 6, 2026
• Inogen Inc. Files 8-K on Financials — Nov 5, 2025 Risk: low
  On November 5, 2025, Inogen Inc. filed an 8-K report. The filing pertains to the company's results of operations and financial condition, as well as financial s
• Inogen Inc. Files 8-K on Financials — Aug 7, 2025 Risk: low
  On August 7, 2025, Inogen Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financ
• Inogen Appoints New Chief Commercial Officer — Jul 29, 2025 Risk: medium
  Inogen Inc. announced on July 24, 2025, a change in its executive team. The company appointed Brent Burns as its new Chief Commercial Officer, effective July 24
• Inogen Inc. Files 8-K: Officer Changes & Shareholder Votes — May 19, 2025 Risk: medium
  Inogen Inc. filed an 8-K on May 19, 2025, reporting events as of May 14, 2025. The filing covers the departure of directors or certain officers, election of dir
• Inogen Inc. Relocates Principal Executive Offices — May 7, 2025 Risk: low
  On May 7, 2025, Inogen Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 859 Ward Drive, Goleta, Californi
• Inogen Inc. Files 8-K on Financials — Feb 25, 2025 Risk: low
  On February 25, 2025, Inogen Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as fin
• Inogen Inc. Files 8-K: Board Changes and Executive Compensation Updates — Feb 3, 2025 Risk: medium
  On January 30, 2025, Inogen Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes the election of
• Inogen Inc. Files 8-K: Material Agreement, Equity Sales — Jan 27, 2025 Risk: medium
  On January 25, 2025, Inogen Inc. entered into a Material Definitive Agreement. The company also disclosed unregistered sales of equity securities and provided a
• Inogen Inc. Files 8-K on Financials — Jan 13, 2025 Risk: low
  On January 13, 2025, Inogen Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as fina
• Inogen Inc. Files 8-K with Financial Statements — Dec 30, 2024 Risk: low
  On December 30, 2024, Inogen Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating potential updates or disclosu
• Inogen Inc. Files 8-K on Financials — Nov 7, 2024 Risk: low
  On November 7, 2024, Inogen Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as fina
• Inogen Inc. Files 8-K on Financials — Aug 6, 2024 Risk: low
  On August 6, 2024, Inogen Inc. filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations, indicating a need
• Inogen CFO Departs, Interim Appointed — Jul 31, 2024 Risk: medium
  Inogen Inc. announced on July 26, 2024, the departure of its Chief Financial Officer, Michael T. Flannery, effective immediately. The company has appointed Paul
• Inogen Appoints New CFO, Michael T. Lio — Jul 3, 2024 Risk: medium
  Inogen Inc. announced on July 2, 2024, the appointment of Michael T. Lio as its new Chief Financial Officer, effective immediately. Lio previously served as the
• Inogen Inc. Elects New Directors, Files 8-K — Jun 7, 2024 Risk: low
  Inogen Inc. announced on June 5, 2024, the election of two new directors, Dr. Jonathan M. Weisberg and Ms. Sarah E. Empey, to its Board of Directors, effective
• Inogen CFO Departs, Interim Appointed; CEO Employment Agreement — May 15, 2024 Risk: medium
  Inogen Inc. announced on May 10, 2024, the departure of its Chief Financial Officer, Michael L. Borchardt, effective May 15, 2024. The company also announced th
• Inogen Inc. Files 8-K on Financials — May 7, 2024 Risk: low
  On May 7, 2024, Inogen Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements and exhibi
• Inogen Appoints New CFO, Michael J. Johnson — Apr 15, 2024 Risk: medium
  On April 11, 2024, Inogen Inc. announced the appointment of Michael J. Johnson as its new Chief Financial Officer, effective April 15, 2024. Johnson previously
• Inogen Inc. Files 8-K for Financial Results Disclosure — Feb 27, 2024 Risk: low
  Inogen Inc. filed a Form 8-K on February 27, 2024, to report on its "Results of Operations and Financial Condition" and to include "Financial Statements and Exh
• Inogen 8-K: Leadership Changes & Compensation Disclosed — Jan 24, 2024
  Inogen Inc. filed an 8-K on January 24, 2024, reporting that the earliest event occurred on January 21, 2024. This filing is primarily about changes in director
• Inogen 8-K: Executive Compensation Arrangements Updated — Jan 5, 2024
  Inogen Inc. filed an 8-K on January 5, 2024, reporting an event that occurred on January 2, 2024, related to changes in its executive compensation arrangements.

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX